Biomarker Cost-Benefit Analysis of EFNEP

Status unconfirmed · Not applicable

Conditions studied: Chronic Disease

In brief

The goal of this integrated project is to assess whether EFNEP is a cost-effective nutrition education intervention that generates sustained improvement in chronic disease biomarkers. This project will be unique in its use of objective biomarkers, instead of self-reported behaviors, to quantify the economic benefits generated by EFNEP through chronic disease prevention. A paired location untreated control group quasi-experimental design will be employed, with biomarkers (BMI, blood pressure, HbA1c) measured for 500 adults across four representative state EFNEP programs (CO, FL, MD, WA). Biomarkers will be measured pre-EFNEP, 6-months-post-EFNEP and 1-year-post-EFNEP. Analytical techniques will include cost-benefit, bivariate, and multivariate analyses.

Key facts

Study ID

NCT05558085

Run by

South Dakota State University

People needed

500

Starts

2022-09-26

Expected to finish

2024-12-31

Last updated by the study team

2023-04-12

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Free-Living
• Speaks and understands English and/or Spanish
• Income at or below 185% of the Federal Poverty Line

You may not qualify if…

• Being pregnant, nursing, and/or less than 9-months postpartum

Where it is running

• University of Florida — Gainesville, Florida, United States (enrolling)
• University of Maryland — College Park, Maryland, United States (enrolling)
• Washington State University — Pullman, Washington, United States (enrolling)
• Colorado State University — Fort Collins, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.